{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T21:54:59Z","timestamp":1773093299518,"version":"3.50.1"},"reference-count":30,"publisher":"American Society of Hematology","issue":"12","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2004,6,15]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The cells of hematopoietic and vascular endothelial cell lineages are believed to share a common precursor, termed hemangioblast. However, the existence of a growth factor acting relatively specifically on hemangioblasts remains unclear. Here we report the identification of hemangiopoietin (HAPO), a novel growth factor acting on both hematopoietic and endothelial cell lineages. In vitro in the human system, recombinant human HAPO (rhHAPO) significantly stimulated the proliferation and hematopoietic and\/or endothelial differentiation of human bone marrow mononuclear cells and of purified CD34+, CD133+, kinase domain receptor-positive (KDR+), or CD34+\/KDR+ cell populations. In the murine system, rhHAPO stimulated the proliferation of long-term culture-initiating cells (LTC-ICs) as well as CD34+ and stem cell antigen-1 (Sca-1+) cell subsets. In vivo, subcutaneous injection of rhHAPO into normal mice resulted in a significant increase in bone marrow hematopoietic cells. Furthermore, irradiated mice injected with rhHAPO had an enhanced survival rate and accelerated hematopoiesis. Our data suggest that HAPO is a novel growth factor acting on the primitive cells of both hematopoietic and endothelial cell lineages and that HAPO may have a clinical potential in the treatment of various cytopenias and radiation injury and in the expansion of hematopoietic and endothelial stem\/progenitor cells. (Blood. 2004;103:4449-4456)<\/jats:p>","DOI":"10.1182\/blood-2003-06-1825","type":"journal-article","created":{"date-parts":[[2004,2,24]],"date-time":"2004-02-24T01:49:31Z","timestamp":1077587371000},"page":"4449-4456","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":51,"title":["Hemangiopoietin, a novel human growth factor for the primitive cells of both hematopoietic and endothelial cell lineages"],"prefix":"10.1182","volume":"103","author":[{"given":"Yong Jun","family":"Liu","sequence":"first","affiliation":[{"name":"From the State Key Laboratory of Experimental Hematology and National Research Center for Stem Cell Engineering and Technology, Institute of Hematology and Hospital of Blood Diseases, Chinese Academy of Medical Sciences and Peking Union of Medical College, Tianjin, China; and Union Stem Cells Gene Engineering, Tianjin, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shi Hong","family":"Lu","sequence":"additional","affiliation":[{"name":"From the State Key Laboratory of Experimental Hematology and National Research Center for Stem Cell Engineering and Technology, Institute of Hematology and Hospital of Blood Diseases, Chinese Academy of Medical Sciences and Peking Union of Medical College, Tianjin, China; and Union Stem Cells Gene Engineering, Tianjin, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bin","family":"Xu","sequence":"additional","affiliation":[{"name":"From the State Key Laboratory of Experimental Hematology and National Research Center for Stem Cell Engineering and Technology, Institute of Hematology and Hospital of Blood Diseases, Chinese Academy of Medical Sciences and Peking Union of Medical College, Tianjin, China; and Union Stem Cells Gene Engineering, Tianjin, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ren Chi","family":"Yang","sequence":"additional","affiliation":[{"name":"From the State Key Laboratory of Experimental Hematology and National Research Center for Stem Cell Engineering and Technology, Institute of Hematology and Hospital of Blood Diseases, Chinese Academy of Medical Sciences and Peking Union of Medical College, Tianjin, China; and Union Stem Cells Gene Engineering, Tianjin, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qian","family":"Ren","sequence":"additional","affiliation":[{"name":"From the State Key Laboratory of Experimental Hematology and National Research Center for Stem Cell Engineering and Technology, Institute of Hematology and Hospital of Blood Diseases, Chinese Academy of Medical Sciences and Peking Union of Medical College, Tianjin, China; and Union Stem Cells Gene Engineering, Tianjin, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bin","family":"Liu","sequence":"additional","affiliation":[{"name":"From the State Key Laboratory of Experimental Hematology and National Research Center for Stem Cell Engineering and Technology, Institute of Hematology and Hospital of Blood Diseases, Chinese Academy of Medical Sciences and Peking Union of Medical College, Tianjin, China; and Union Stem Cells Gene Engineering, Tianjin, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bin","family":"Li","sequence":"additional","affiliation":[{"name":"From the State Key Laboratory of Experimental Hematology and National Research Center for Stem Cell Engineering and Technology, Institute of Hematology and Hospital of Blood Diseases, Chinese Academy of Medical Sciences and Peking Union of Medical College, Tianjin, China; and Union Stem Cells Gene Engineering, Tianjin, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Min","family":"Lu","sequence":"additional","affiliation":[{"name":"From the State Key Laboratory of Experimental Hematology and National Research Center for Stem Cell Engineering and Technology, Institute of Hematology and Hospital of Blood Diseases, Chinese Academy of Medical Sciences and Peking Union of Medical College, Tianjin, China; and Union Stem Cells Gene Engineering, Tianjin, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Feng Ying","family":"Yan","sequence":"additional","affiliation":[{"name":"From the State Key Laboratory of Experimental Hematology and National Research Center for Stem Cell Engineering and Technology, Institute of Hematology and Hospital of Blood Diseases, Chinese Academy of Medical Sciences and Peking Union of Medical College, Tianjin, China; and Union Stem Cells Gene Engineering, Tianjin, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhi Bo","family":"Han","sequence":"additional","affiliation":[{"name":"From the State Key Laboratory of Experimental Hematology and National Research Center for Stem Cell Engineering and Technology, Institute of Hematology and Hospital of Blood Diseases, Chinese Academy of Medical Sciences and Peking Union of Medical College, Tianjin, China; and Union Stem Cells Gene Engineering, Tianjin, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhong Chao","family":"Han","sequence":"additional","affiliation":[{"name":"From the State Key Laboratory of Experimental Hematology and National Research Center for Stem Cell Engineering and Technology, Institute of Hematology and Hospital of Blood Diseases, Chinese Academy of Medical Sciences and Peking Union of Medical College, Tianjin, China; and Union Stem Cells Gene Engineering, Tianjin, China."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"234","reference":[{"key":"2020021220463372700_REF1","unstructured":"Han ZC, Caen JP. Are megakaryocytes and endothelial cells sisters? J Lab Clin Med. 1993;121: 821-825."},{"key":"2020021220463372700_REF2","unstructured":"Bikfalvi A, Han ZC. Angiogenic factors are hematopoietic growth factors and vice versa. Leukemia. 1994;8: 523-529."},{"key":"2020021220463372700_REF3","doi-asserted-by":"crossref","unstructured":"Choi K, Kennedy M, Kazarov A, Papadimitriou JC, Keller G. A common precursor for hematopoietic and endothelial cells. Development. 1998;125: 725-732.","DOI":"10.1242\/dev.125.4.725"},{"key":"2020021220463372700_REF4","doi-asserted-by":"crossref","unstructured":"Chung YS, Zhang WJ, Arentson E, Kingsley PD, Palis J, Choi K. Lineage analysis of the hemangioblast as defined by FLK1 and SCL expression. Development. 2002;129: 5511-5520.","DOI":"10.1242\/dev.00149"},{"key":"2020021220463372700_REF5","doi-asserted-by":"crossref","unstructured":"Ziegler BL, Valtieri M, Porada GA, et al. KDR receptor: a key marker defining hematopoietic stem cells. Science. 1999;285: 1553-1558.","DOI":"10.1126\/science.285.5433.1553"},{"key":"2020021220463372700_REF6","doi-asserted-by":"crossref","unstructured":"Shalaby F, Ho J, Stanford WL, et al. A requirement for flk-1 in primitive and definitive hematopoiesis and vasculogenesis. Cell. 1997;89: 981-990.","DOI":"10.1016\/S0092-8674(00)80283-4"},{"key":"2020021220463372700_REF7","doi-asserted-by":"crossref","unstructured":"Shalaby F, Rossant J, Yamaguchi TP, et al. Failure of blood-island formation and vasculogenesis in FLK-1 deficient mice. Nature. 1995;376: 62-66.","DOI":"10.1038\/376062a0"},{"key":"2020021220463372700_REF8","doi-asserted-by":"crossref","unstructured":"Nishikawa SI, Nishikawa S, Hirashima M, Matsuyoshi N, Kodama H. Progressive lineage analysis by cell sorting and culture identifies FLK1+VE-cadherin+ cells at a diverging point of endothelial and hemopoietic lineages. Development. 1998;125: 1747-1757.","DOI":"10.1242\/dev.125.9.1747"},{"key":"2020021220463372700_REF9","doi-asserted-by":"crossref","unstructured":"Grant MB, May WS, Caballero S, et al. Adult hematopoietic stem cells provide functional hemangioblast activity during retinal neovascularization. Nat Med. 2002;8: 607-612.","DOI":"10.1038\/nm0602-607"},{"key":"2020021220463372700_REF10","doi-asserted-by":"crossref","unstructured":"Pelosi E, Valtieri M, Coppola S, et al. Identification of the hemangioblast in postnatal life. Blood. 2002;100: 3203-3208.","DOI":"10.1182\/blood-2002-05-1511"},{"key":"2020021220463372700_REF11","doi-asserted-by":"crossref","unstructured":"Peichev M, Naiyer AJ, Pereira D, et al. Expression of VEGFR-2 and AC133 by circulating human CD34+ cells identifies a population of functional endothelial precursors. Blood. 2000;95: 952-958.","DOI":"10.1182\/blood.V95.3.952.003k27_952_958"},{"key":"2020021220463372700_REF12","unstructured":"De Bont ES, Guikema JE, Scherpen F, et al. Mobilized human CD34+ hematopoietic stem cells enhance tumor growth in a nonobese diabetic\/severe combined immunodeficient mouse model of human non-Hodgkin's lymphoma. Cancer Res. 2001;61: 7654-7659."},{"key":"2020021220463372700_REF13","doi-asserted-by":"crossref","unstructured":"Shi Q, Rafii S, Wu MH, et al. Evidence for circulating bone marrow-derived endothelial cells. Blood. 1998;92: 362-367.","DOI":"10.1182\/blood.V92.2.362"},{"key":"2020021220463372700_REF14","doi-asserted-by":"crossref","unstructured":"Gehling UM, Ergun S, Schumacher U, et al. In vitro differentiation of endothelial cells from AC133-positive progenitor cells. Blood. 2000;95: 3106-3112.","DOI":"10.1182\/blood.V95.10.3106"},{"key":"2020021220463372700_REF15","doi-asserted-by":"crossref","unstructured":"Quirici N, Soligo D, Caneva L, Servida F, Bossolasco P, Deliliers GL. Differentiation and expansion of endothelial cells from human bone marrow CD133(+) cells. Br J Haematol. 2001;115: 186-194.","DOI":"10.1046\/j.1365-2141.2001.03077.x"},{"key":"2020021220463372700_REF16","doi-asserted-by":"crossref","unstructured":"Ribatti D, Vacca A, De Falco G, Ria R, Roncali L, Dammacco F. Role of hematopoietic growth factors in angiogenesis. Acta Haematol. 2001;106: 157-161.","DOI":"10.1159\/000046611"},{"key":"2020021220463372700_REF17","doi-asserted-by":"crossref","unstructured":"Jaquet K, Krause K, Tawakol-Khodai M, Geidel S, Kuck KH. Erythropoietin and VEGF exhibit equal angiogenic potential. Microvasc Res. 2002;64: 326-333.","DOI":"10.1006\/mvre.2002.2426"},{"key":"2020021220463372700_REF18","doi-asserted-by":"crossref","unstructured":"Han ZC, Lu M, Xi XD, et al. Platelet factor 4 and other CXC chemokines support the survival of normal hematopoietic cells and reduce the chemosensitivity of cells to cytotoxic agents. Blood. 1997;89: 2328-2335.","DOI":"10.1182\/blood.V89.7.2328"},{"key":"2020021220463372700_REF19","doi-asserted-by":"crossref","unstructured":"Aidoudi S, Guigon M, Lebeurier I, Caen JP, Han ZC. In vivo effect of platelet factor 4 (PF4) and tetrapeptide AcSDKP on hematopoiesis of mice treated by 5-fluorouracil. Br J Haematol. 1996;94: 443-448.","DOI":"10.1046\/j.1365-2141.1996.d01-1821.x"},{"key":"2020021220463372700_REF20","doi-asserted-by":"crossref","unstructured":"Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanatephenol-chloroform extraction. Anal Biochem. 1987;162: 156-159.","DOI":"10.1016\/0003-2697(87)90021-2"},{"key":"2020021220463372700_REF21","doi-asserted-by":"crossref","unstructured":"Rizzo S, Scopes J, Elebute MO, Papadaki HA, Gordon-Smith EC, Gibson FM. Stem cell defect in aplastic anemia: reduced long term culture-initiating cells (LTC-IC) in CD34+ cells isolated from aplastic anemia patient bone marrow. Hematol J. 2002;3: 230-236.","DOI":"10.1038\/sj.thj.6200187"},{"key":"2020021220463372700_REF22","doi-asserted-by":"crossref","unstructured":"Leary AG, Yang YC, Clark SC, Golde DW, Ogawa M. Recombinant gibbon interleukin-3 supports formation of human multilineage colonies and blast cell colonies culture: comparison with recombinant human granulocyte-macrophage colony-stimulating factor. Blood1987;70: 1343-1348.","DOI":"10.1182\/blood.V70.5.1343.bloodjournal7051343"},{"key":"2020021220463372700_REF23","doi-asserted-by":"crossref","unstructured":"Ikegawa S, Sano M, Koshizuka Y, Nakamura Y. Isolation, characterization and mapping of the mouse and human PRG4 (proteoglycan 4) genes. Cytogenet Cell Genet. 2000;90: 291-297.","DOI":"10.1159\/000056791"},{"key":"2020021220463372700_REF24","doi-asserted-by":"crossref","unstructured":"Flannery CR, Hughes CE, Schumacher BL, et al. Articular cartilage superficial zone protein (SZP) is homologous to megakaryocyte stimulating factor precursor and is a multifunctional proteoglycan with potential growth-promoting, cytoprotective, and lubricating properties in cartilage metabolism. Biochem Biophys Res Commun. 1999;254: 535-541.","DOI":"10.1006\/bbrc.1998.0104"},{"key":"2020021220463372700_REF25","unstructured":"Turner KJ, Fitz LJ, Temple P, et al. Purification, biochemical characterization, and cloning of a novel megakaryocyte stimulating factor that has megakaryocyte colony stimulating activity [abstract]. Blood. 1991;78: 279a."},{"key":"2020021220463372700_REF26","doi-asserted-by":"crossref","unstructured":"Lebeurier I, Basara N, Aidoudi S, Amiral J, Caen JP, Han ZC. Carboxy-terminal peptides (C1-24 and C13-24 but not C1-13) of platelet factor 4 inhibit murine megakaryocytopoiesis, an activity which is neutralized by heparin. Br J Haematol. 1996;92: 29-34.","DOI":"10.1046\/j.1365-2141.1996.296828.x"},{"key":"2020021220463372700_REF27","doi-asserted-by":"crossref","unstructured":"Maciejewski JP, Risitano A, Kook H, Zeng W, Chen G, Young NS. Immune pathophysiology of aplastic anemia. Int J Hematol. 2002;76(suppl 1): 207-214.","DOI":"10.1007\/BF03165246"},{"key":"2020021220463372700_REF28","doi-asserted-by":"crossref","unstructured":"Zsebo KM, Smith KA, Hartley CA, et al. Radioprotection of mice by recombinant rat stem cell factor. Proc Natl Acad Sci U S A. 1992;89: 9464-9468.","DOI":"10.1073\/pnas.89.20.9464"},{"key":"2020021220463372700_REF29","doi-asserted-by":"crossref","unstructured":"Gratwohl A, John L, Baldomero H, et al. FLT-3 ligand provides hematopoietic protection from total body irradiation in rabbits. Blood. 1998;92: 765-769.","DOI":"10.1182\/blood.V92.3.765"},{"key":"2020021220463372700_REF30","doi-asserted-by":"crossref","unstructured":"Mouthon MA, Van der Meeren A, Gaugler MH, et al. Thrombopoietin promotes hematopoietic recovery and survival after high-dose whole body irradiation. Int J Radiat Oncol Biol Phys. 1999;43: 867-875.","DOI":"10.1016\/S0360-3016(98)00477-5"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/103\/12\/4449\/1698247\/zh801204004449.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/103\/12\/4449\/1698247\/zh801204004449.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,14]],"date-time":"2021-06-14T21:23:24Z","timestamp":1623705804000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/103\/12\/4449\/131391\/Hemangiopoietin-a-novel-human-growth-factor-for"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,6,15]]},"references-count":30,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2004,6,15]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2003-06-1825","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,6,15]]}}}